386 related articles for article (PubMed ID: 28039287)
1. Vascular biomarkers to predict response to exercise in Alzheimer's disease: the study protocol.
Li D; Thomas R; Tsai MY; Li L; Vock DM; Greimel S; Yu F
BMJ Open; 2016 Dec; 6(12):e011054. PubMed ID: 28039287
[TBL] [Abstract][Full Text] [Related]
2. Effects of aerobic exercise on cognition and hippocampal volume in Alzheimer's disease: study protocol of a randomized controlled trial (The FIT-AD trial).
Yu F; Bronas UG; Konety S; Nelson NW; Dysken M; Jack C; Wyman JF; Vock D; Smith G
Trials; 2014 Oct; 15():394. PubMed ID: 25304364
[TBL] [Abstract][Full Text] [Related]
3. Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial.
Yu F; Vock DM; Zhang L; Salisbury D; Nelson NW; Chow LS; Smith G; Barclay TR; Dysken M; Wyman JF
J Alzheimers Dis; 2021; 80(1):233-244. PubMed ID: 33523004
[TBL] [Abstract][Full Text] [Related]
4. Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial).
Li D; Mielke MM; Bell WR; Reilly C; Zhang L; Lin FV; Yu F
Trials; 2020 Jan; 21(1):19. PubMed ID: 31907024
[TBL] [Abstract][Full Text] [Related]
5. Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study.
Eriksdotter M; Vedin I; Falahati F; Freund-Levi Y; Hjorth E; Faxen-Irving G; Wahlund LO; Schultzberg M; Basun H; Cederholm T; Palmblad J
J Alzheimers Dis; 2015; 48(3):805-12. PubMed ID: 26402079
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and mechanisms of combined aerobic exercise and cognitive training in mild cognitive impairment: study protocol of the ACT trial.
Yu F; Lin FV; Salisbury DL; Shah KN; Chow L; Vock D; Nelson NW; Porsteinsson AP; Jack C
Trials; 2018 Dec; 19(1):700. PubMed ID: 30577848
[TBL] [Abstract][Full Text] [Related]
7. Study protocol for Vitality: a proof-of-concept randomised controlled trial of exercise training or complex mental and social activities to promote cognition in adults with chronic stroke.
Best JR; Eng JJ; Davis JC; Hsiung R; Hall PA; Middleton LE; Graf P; Goldsmith CH; Liu-Ambrose T
BMJ Open; 2018 Mar; 8(3):e021490. PubMed ID: 29550783
[TBL] [Abstract][Full Text] [Related]
8. Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.
Hoffmann K; Sobol NA; Frederiksen KS; Beyer N; Vogel A; Vestergaard K; Brændgaard H; Gottrup H; Lolk A; Wermuth L; Jacobsen S; Laugesen LP; Gergelyffy RG; Høgh P; Bjerregaard E; Andersen BB; Siersma V; Johannsen P; Cotman CW; Waldemar G; Hasselbalch SG
J Alzheimers Dis; 2016; 50(2):443-53. PubMed ID: 26682695
[TBL] [Abstract][Full Text] [Related]
9. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment.
Köbe T; Witte AV; Schnelle A; Lesemann A; Fabian S; Tesky VA; Pantel J; Flöel A
Neuroimage; 2016 May; 131():226-38. PubMed ID: 26433119
[TBL] [Abstract][Full Text] [Related]
10. Multifaceted intervention to enhance cognition in older people at risk of cognitive decline: study protocol for the Protein Omega-3 and Vitamin D Exercise Research (PONDER) study.
Macpherson H; Brownell S; Duckham RL; Meyer B; Mirzaee S; Daly RM
BMJ Open; 2019 May; 9(5):e024145. PubMed ID: 31072850
[TBL] [Abstract][Full Text] [Related]
11. Impact of 6-month aerobic exercise on Alzheimer's symptoms.
Yu F; Thomas W; Nelson NW; Bronas UG; Dysken M; Wyman JF
J Appl Gerontol; 2015 Jun; 34(4):484-500. PubMed ID: 24652914
[TBL] [Abstract][Full Text] [Related]
12. Cognitive activity for the treatment of older adults with mild Alzheimer's disease (AD)--PACE AD: study protocol for a randomised controlled trial.
Vidovich MR; Shaw J; Flicker L; Almeida OP
Trials; 2011 Feb; 12():47. PubMed ID: 21329501
[TBL] [Abstract][Full Text] [Related]
13. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study.
Jernerén F; Cederholm T; Refsum H; Smith AD; Turner C; Palmblad J; Eriksdotter M; Hjorth E; Faxen-Irving G; Wahlund LO; Schultzberg M; Basun H; Freund-Levi Y
J Alzheimers Dis; 2019; 69(1):189-197. PubMed ID: 30958356
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic Effects of Aerobic Exercise in Alzheimer's Disease: Imaging Findings From the Pilot FIT-AD Trial.
Yu F; Mathiason MA; Han S; Gunter JL; Jones D; Botha H; Jack C
Front Aging Neurosci; 2021; 13():703691. PubMed ID: 34690736
[TBL] [Abstract][Full Text] [Related]
16. Inter-individual differences in the responses to aerobic exercise in Alzheimer's disease: Findings from the FIT-AD trial.
Yu F; Salisbury D; Mathiason MA
J Sport Health Sci; 2021 Jan; 10(1):65-72. PubMed ID: 32505710
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Aerobic Exercise on Cognitive Function of Alzheimer's Disease Patients.
Yang SY; Shan CL; Qing H; Wang W; Zhu Y; Yin MM; Machado S; Yuan TF; Wu T
CNS Neurol Disord Drug Targets; 2015; 14(10):1292-7. PubMed ID: 26556080
[TBL] [Abstract][Full Text] [Related]
18. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
Wattmo C; Wallin ÅK
Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
[TBL] [Abstract][Full Text] [Related]
19. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease.
Shinto L; Quinn J; Montine T; Dodge HH; Woodward W; Baldauf-Wagner S; Waichunas D; Bumgarner L; Bourdette D; Silbert L; Kaye J
J Alzheimers Dis; 2014; 38(1):111-20. PubMed ID: 24077434
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
